PI
CLVS

Putnam Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Putnam Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-140,218
Closed -$2.08M – 952
2019
Q2 		$2.08M Sell
140,218
-258,057
-65% -$4.66M ﹤0.01% 719
2019
Q1 		$9.89M Sell
398,275
-587,228
-60% -$14.7M 0.02% 355
2018
Q4 		$17.7M Sell
985,503
-91,680
-9% -$1.87M 0.05% 239
2018
Q3 		$31.6M Buy
1,077,183
+472,529
+78% +$18.3M 0.07% 207
2018
Q2 		$27.5M Sell
604,654
-380,319
-39% -$18.5M 0.06% 218
2018
Q1 		$52M Buy
984,973
+190
+0% +$11.1K 0.12% 171
2017
Q4 		$67M Buy
984,783
+157,628
+19% +$11M 0.15% 150
2017
Q3 		$68.2M Buy
827,155
+247,912
+43% +$19.7M 0.16% 147
2017
Q2 		$54.2M Buy
579,243
+459,901
+385% +$28.1M 0.13% 155
2017
Q1 		$7.6M Buy
119,342
+76,157
+176% +$4.63M 0.02% 457
2016
Q4 		$1.92M Sell
43,185
-2,513
-5% -$88.4K ﹤0.01% 850
2016
Q3 		$1.65M Sell
45,698
-6,769
-13% -$145K ﹤0.01% 899
2016
Q2 		$720K Buy
52,467
+25,244
+93% +$369K ﹤0.01% 1150
2016
Q1 		$523K Sell
27,223
-4,373
-14% -$92.6K ﹤0.01% 1238
2015
Q4 		$1.11M Buy
+31,596
New +$2.04M ﹤0.01% 1137
2013
Q3 		– Sell
-70,000
Closed -$4.69M – 1508
2013
Q2 		$4.69M Buy
+70,000
New +$3.15M 0.01% 711

Other funds holding CLVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Putnam Investments's CLVS Position: Q3 2019 in Review

Putnam Investments sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 140,218 shares — an estimated $2.08M sold.

Putnam Investments first reported a position in CLVS in Q2 2013 and held it in 16 quarters. The position peaked at $68.2M in Q3 2017. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

  • Putnam Investments reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
  • Putnam Investments sold 140,218 Clovis Oncology, Inc. shares in Q3 2019, an estimated $2.08M.
  • Putnam Investments first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 16 quarters.
  • Putnam Investments's Clovis Oncology, Inc. position peaked at $68.2M in Q3 2017.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Putnam Investments's 13F filing for Q3 2019, filed 14 Nov 2019.